Free fatty acid-induced miR-181a-5p stimulates apoptosis by targeting XIAP and Bcl2 in hepatic cells.

[1]  Renhong Huang,et al.  Exosomes from M1‐polarized macrophages promote apoptosis in lung adenocarcinoma via the miR‐181a‐5p/ETS1/STK16 axis , 2022, Cancer science.

[2]  Ming Ouyang,et al.  microRNA-181a-5p impedes the proliferation, migration, and invasion of retinoblastoma cells by targeting the NRAS proto-oncogene , 2022, Clinics.

[3]  Fei Liang,et al.  Resveratrol inhibited hepatocyte apoptosis and alleviated liver fibrosis through miR-190a-5p /HGF axis. , 2022, Bioorganic & medicinal chemistry.

[4]  Lang Li,et al.  Downregulation of miR-181a-5p alleviates oxidative stress and inflammation in coronary microembolization-induced myocardial damage by directly targeting XIAP , 2021, Journal of geriatric cardiology : JGC.

[5]  T. Takahara,et al.  Hydrogen-rich water protects liver injury in nonalcoholic steatohepatitis though HO-1 enhancement via IL-10 and Sirt 1 signaling. , 2021, American journal of physiology. Gastrointestinal and liver physiology.

[6]  X-Q Cao,et al.  Long non-coding RNA LUCAT1 inhibits myocardial oxidative stress and apoptosis after myocardial infarction via targeting microRNA-181a-5p , 2021, Bioengineered.

[7]  D. Nakae,et al.  A trans fatty acid substitute enhanced development of liver proliferative lesions induced in mice by feeding a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet , 2020, Lipids in health and disease.

[8]  Qiong Chen,et al.  Inhibition of miR‐181a attenuates sepsis‐induced inflammation and apoptosis by activating Nrf2 and inhibiting NF‐κB pathways via targeting SIRT1 , 2020, The Kaohsiung journal of medical sciences.

[9]  Zhiyuan Chen,et al.  MiR-149 attenuates endoplasmic reticulum stress-induced inflammation and apoptosis in nonalcoholic fatty liver disease by negatively targeting ATF6 pathway. , 2020, Immunology letters.

[10]  Linfeng Hu,et al.  Effects of XIAP on high fat diet-induced hepatic steatosis: a mechanism involving NLRP3 inflammasome and oxidative stress , 2019, Aging.

[11]  Parul Gupta,et al.  TGF-β induces liver fibrosis via miRNA-181a-mediated down regulation of augmenter of liver regeneration in hepatic stellate cells , 2019, PloS one.

[12]  Yuqin Wang,et al.  Upregulation of miR-181a impairs lipid metabolism by targeting PPARα expression in nonalcoholic fatty liver disease. , 2019, Biochemical and biophysical research communications.

[13]  T. Maruyama,et al.  Detection of Serum miRNAs Affecting Liver Apoptosis in a Periodontitis Rat Model , 2019, In Vivo.

[14]  M. Yamazaki,et al.  Apoptosis and non-alcoholic fatty liver diseases , 2018, World journal of gastroenterology.

[15]  Jia-guo Zhou,et al.  Renal inhibition of miR-181a ameliorates 5-fluorouracil-induced mesangial cell apoptosis and nephrotoxicity , 2018, Cell Death & Disease.

[16]  Taotao Ma,et al.  MicroRNA-200a induces apoptosis by targeting ZEB2 in alcoholic liver disease , 2017, Cell cycle.

[17]  M. Zhang,et al.  Upregulation of miR-181a impairs hepatic glucose and lipid homeostasis , 2017, Oncotarget.

[18]  Zongguang Zhou,et al.  miR-181a-5p promotes the progression of gastric cancer via RASSF6-mediated MAPK signalling activation. , 2017, Cancer letters.

[19]  A. Saraya,et al.  Butyrate induces ROS-mediated apoptosis by modulating miR-22/SIRT-1 pathway in hepatic cancer cells , 2017, Redox biology.

[20]  Jing Wang,et al.  Prolyl Oligopeptidase Inhibition Attenuates Steatosis in the L02 Human Liver Cell Line , 2016, PloS one.

[21]  Juntao Yang,et al.  Lipid deposition in liver cells: The influence of short form augmenter of liver regeneration. , 2016, Clinics and research in hepatology and gastroenterology.

[22]  Yan Guo,et al.  A micro-RNA expression signature for human NAFLD progression , 2016, Journal of Gastroenterology.

[23]  C. Still,et al.  High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis. , 2015, Translational research : the journal of laboratory and clinical medicine.

[24]  Botao Zhao,et al.  MiR-181a-5p inhibits cell proliferation and migration by targeting Kras in non-small cell lung cancer A549 cells. , 2015, Acta biochimica et biophysica Sinica.

[25]  G. Gores,et al.  Lipoapoptosis induced by saturated free fatty acids stimulates monocyte migration: a novel role for Pannexin1 in liver cells , 2015, Purinergic Signalling.

[26]  C. Byrne,et al.  NAFLD: a multisystem disease. , 2015, Journal of hepatology.

[27]  Jun Yu,et al.  microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K/AKT pathway , 2014, Oncotarget.

[28]  D. Häussinger,et al.  Free Fatty Acids Shift Insulin-induced Hepatocyte Proliferation towards CD95-dependent Apoptosis* , 2014, The Journal of Biological Chemistry.

[29]  E. Hasby,et al.  Apoptotic and anti-apoptotic seromarkers for assessment of disease severity of non-alcoholic steatohepatitis. , 2014, Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology.

[30]  C. Tanaka,et al.  An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis , 2013, International journal of experimental pathology.

[31]  F. Xiao,et al.  Pannexin1 contributes to pathophysiological ATP release in lipoapoptosis induced by saturated free fatty acids in liver cells. , 2012, American journal of physiology. Cell physiology.

[32]  H. Cortez‐Pinto,et al.  Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease , 2011, Diabetologia.

[33]  Á. Valverde,et al.  Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C. , 2011, Journal of hepatology.

[34]  H. Thomas,et al.  Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis. , 2010, Journal of hepatology.

[35]  Vanessa S Teaberry,et al.  Pan‐caspase inhibitor VX‐166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis , 2009, Hepatology.

[36]  A. Feldstein,et al.  Cytokeratin‐18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study , 2009, Hepatology.

[37]  C. Hellerbrand,et al.  Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells , 2009, Cell Research.

[38]  Puneet Puri,et al.  Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression , 2008, Hepatology.

[39]  Lisa M Yerian,et al.  In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease , 2006, Hepatology.

[40]  G. Gores,et al.  Free Fatty Acids Induce JNK-dependent Hepatocyte Lipoapoptosis* , 2006, Journal of Biological Chemistry.

[41]  H. Cortez‐Pinto,et al.  Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis , 2006, European journal of gastroenterology & hepatology.

[42]  M. Prentki,et al.  Glucagon-like peptide-1 prevents beta cell glucolipotoxicity , 2004, Diabetologia.

[43]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[44]  M. Roden,et al.  Free fatty acids trigger apoptosis and inhibit cell cycle progression in human vascular endothelial cells , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  M. Prentki,et al.  Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death. , 2003, Endocrinology.

[46]  G. Gores,et al.  Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. , 2003, Gastroenterology.

[47]  H. Mischak,et al.  Protein Kinase C δ Activation and Translocation to the Nucleus Are Required for Fatty Acid-Induced Apoptosis of Insulin-Secreting Cells , 2003 .

[48]  Emad S. Alnemri,et al.  A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis , 2001, Nature.

[49]  M. Hengartner.  The biochemistry of apoptosis , 2000, Nature.

[50]  G. Feldmann.  Liver apoptosis. , 1997, Journal of hepatology.